Fig. 1. Bexarotene promotes PPARδ activation to ameliorate the neurotoxicity of mutant huntingtin. Bexarotene promotes PPARδ activation to ameliorate the.

Slides:



Advertisements
Similar presentations
 Dominant neurodegenerative disease  Polyglutamine repeat expansions (CAG, codon, Q) in exon 1 of huntingtin gene (htt). Usually >35 CAG repeats. 
Advertisements

Figure 1 miR-128, miR-27 and miR-340 are overexpressed in multiple sclerosis CD4+ T cells. (A) miR-128 (left) and miR-27a or miR-27b (right)
Inhibition of hypoxia-induced cyclooxygenase-2 by Korean Red Ginseng is dependent on peroxisome proliferator-activated receptor gamma  Heewon Song, Young.
Fig. 6. Transgenic expression of αLNNd and mag in dyW/dyW mice improves muscle function, increases body weight, and prolongs life span. Transgenic expression.
LTB4 production is elevated in preclinical and clinical lymphedema
Fig. 7. Downstream effects of α-synuclein on mitochondria.
Yongping Shao, Kaitlyn Le, Hanyin Cheng, Andrew E. Aplin 
Set9 inhibits oxidative stress‐induced neuronal cell death via methylation of FOXO3. Set9 inhibits oxidative stress‐induced neuronal cell death via methylation.
REV-ERBα agonists reduce protein O-GlcNAcylation.
Fig. 1. Potent and selective down-regulation of KRAS mRNA and protein by AZD4785 in vitro and in vivo. Potent and selective down-regulation of KRAS mRNA.
Transfer of miR-223 during neutrophil-epithelial cell interactions
Fig. 5. Circulating PPi concentration does not correlate with severity of calcification phenotype in mice. Circulating PPi concentration does not correlate.
A FOXO3a-BIM cascade mediates sensitivity to PARP and MEK inhibition
BET inhibition and depletion repress the expression of BRCA1 and RAD51
Fig. 4. Bexarotene promotes PPARδ activation of target genes in mouse brain and muscle. Bexarotene promotes PPARδ activation of target genes in mouse brain.
Fig. 2. Mechanism of PD-L1 down-regulation in NOD HSPCs.
Fig. 1. APP/PS1;C3 KO mice show improved cognitive flexibility (reversal) compared to APP/PS1 mice at 16 months of age. APP/PS1;C3 KO mice show improved.
Fig. 3. LTB4 exhibits concentration-dependent effects on HLEC lymphangiogenesis and survival. LTB4 exhibits concentration-dependent effects on HLEC lymphangiogenesis.
Fig. 6. Treatment with a DLK inhibitor is neuroprotective and reverses stress-induced gene expression changes. Treatment with a DLK inhibitor is neuroprotective.
Analysis of brain and spinal cord of treated Gaa−/− mice and controls
Fig. 2 TLR8 is aberrantly expressed on pDCs from SSc patients.
Fig. 6 Bimodal treatment results in reduced tinnitus loudness and reduced TFI scores in human patients. Bimodal treatment results in reduced tinnitus loudness.
Fig. 3. A circadian rhythm in fibroblast wound-healing response.
MRSA virulence proteins cause LMC death and diminished CLV function
Fig. 1 MT-2 ameliorates asthmatic pulmonary resistance.
Fig. 1 ZIKV-related flaviviruses cause fetal demise in mice that can be prevented by mAb treatment. ZIKV-related flaviviruses cause fetal demise in mice.
Fig. 5. Antitumor efficacy of ERY974 in immunocompetent human CD3 transgenic mice. Antitumor efficacy of ERY974 in immunocompetent human CD3 transgenic.
Fig. 4. The effects of AVP or d(Leu4Lys8)VP, a specific AVPR1B agonist, on anemic rodents. The effects of AVP or d(Leu4Lys8)VP, a specific AVPR1B agonist,
Fig. 3. Wisper controls CF behavior and survival.
Fig. 6. HERV-K activation by TDP-43 and identification of binding sites on LTR. (A and B) Stem cell–derived neurons were transfected with either pcDNA.
Fig. 3 Biological function of TG2 and the interaction with MT-2.
Fig. 7 Gel scaffold for inhibition of postsurgical recurrence of B16F10 tumors. Gel scaffold for inhibition of postsurgical recurrence of B16F10 tumors.
Everolimus Inhibits SMC Proliferation Through Transcriptional Repression of Telomerase (A) Cell proliferation assay in primary murine vascular smooth muscle.
Fig. 6. A circadian rhythm in keratinocyte wound healing and a diurnal variation in human burn healing outcome. A circadian rhythm in keratinocyte wound.
Fig. 1. Generation of the ΔEx50 mouse model.
Volume 56, Issue 1, Pages (October 2014)
Fig. 1. Muscles of LAMA2 MD patients and dyW/dyW mice contain high amounts of laminin-α4 and show deficits in BM. Muscles of LAMA2 MD patients and dyW/dyW.
Fig. 4. Expression of HGF in liver ECs cooperates with NOX4 inhibition to enhance engraftment of regenerative hepatocytes. Expression of HGF in liver ECs.
Fig. 2. Circulating VEGF in GCA patients up-regulates microvascular endothelial Jagged1. Circulating VEGF in GCA patients up-regulates microvascular endothelial.
Fig. 7. KIF11 informs patient prognosis, and targeting improves survival in a preclinical model. KIF11 informs patient prognosis, and targeting improves.
Fig. 1. mGlu7 expression is reduced in RTT autopsy samples.
Fig. 3. ERRα is involved in the regulation of OPLAH.
Fig. 1 BX795 suppresses HSV-1 infection.
Fig. 1. Thorase variants show defects in Thorase oligomer and GluA2-GRIP1 complex disassembly. Thorase variants show defects in Thorase oligomer and GluA2-GRIP1.
Fig. 5. Nutlin-3 treatment rescues the proliferation and differentiation of NPCs in vitro. Nutlin-3 treatment rescues the proliferation and differentiation.
by Issam Ben-Sahra, Gerta Hoxhaj, Stéphane J. H. Ricoult, John M
Fig. 3. HECTD2 contains a naturally occurring polymorphism at A19, which mislocalizes to the cytosol. HECTD2 contains a naturally occurring polymorphism.
Bexarotene is neuroprotective in mouse and human HD neurons in vitro
Fig. 1 Differentiation of human peripheral blood monocytes into MDMi cells induces a microglial gene expression and functional phenotype. Differentiation.
The CHCH domain is necessary for mitochondrial import of CHCHD10
Fig. 2. Cellular response to FolamiRs in vitro.
Transcriptional Repression of miR-34 Family Contributes to p63-Mediated Cell Cycle Progression in Epidermal Cells  Dario Antonini, Monia T. Russo, Laura.
Fig. 1. Specificity of FolamiR uptake in cancer cells in culture.
Fig. 6 DMF inhibits NF-κB translocation upon infection.
Reduced phosphorylation of IKKα/β, p65 and delayed IκBα degradation and reduced NF-κB activation in bid−/− microglia. Reduced phosphorylation of IKKα/β,
Verification of NEUROD2 binding to the conserved element within Stim1 intron 2. Verification of NEUROD2 binding to the conserved element within Stim1 intron.
Fig. 2. Thorase variants cause impaired GluA2 endocytosis and trafficking in mouse primary cortical neurons. Thorase variants cause impaired GluA2 endocytosis.
Fig. 1. Generation of the ΔEx50 mouse model.
Fig. 1. Nrf2 affects the mitochondrial membrane potential
ASyn overexpression exacerbates the effect of MPP+ on Ca2+ in SN but not VTA neurons. aSyn overexpression exacerbates the effect of MPP+ on Ca2+ in SN.
Activity-dependent suppression of the proapoptotic gene Puma protects neurons. Activity-dependent suppression of the proapoptotic gene Puma protects neurons.
Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice by Gabrielle Fredman,
Targeting DCLK1 by miRNA-137.
Targeting p53-dependent stem cell loss for intestinal chemoprotection
Fig. 4 ID1 is a direct CREB target.
EGFR signaling regulates transcription of PDGFRβ gene.
Fig. 4. miR promotes cardiomyocyte proliferation through regulation of Hippo pathway kinases. miR promotes cardiomyocyte proliferation through.
Fig. 2. Col IV–Ac2-26 NPs increase subendothelial collagen in Ldlr−/− mice with established atherosclerosis. Col IV–Ac2-26 NPs increase subendothelial.
Fig. 3. Col IV–Ac2-26 NPs suppress lesional superoxide and increase lesional Il10 mRNA in Ldlr−/− mice with established atherosclerosis. Col IV–Ac2-26.
Fig. 2. Cellular response to FolamiRs in vitro.
Presentation transcript:

Fig. 1. Bexarotene promotes PPARδ activation to ameliorate the neurotoxicity of mutant huntingtin. Bexarotene promotes PPARδ activation to ameliorate the neurotoxicity of mutant huntingtin. (A) We measured 3x–PPAR response element luciferase reporter activity in primary cortical neurons from WT control mice or bacterial artificial chromosome transgenic Huntington’s disease (BAC-HD) mice cotransfected with Renilla luciferase vector and treated with bexarotene (500 nM), GW501516 (100 nM), or vehicle. Peroxisome proliferator–activated receptor δ (PPARδ) activation in BAC-HD mouse neurons was repressed at baseline compared to wild-type (WT) mouse neurons. **P < 0.01, Student’s t test. Bexarotene and GW501516 treatment promoted PPARδ activation in BAC-HD mouse neurons. **P < 0.01, analysis of variance (ANOVA) with post-hoc Tukey test. n = 3 biological replicates; n = 3 technical replicates. Results were normalized to WT mouse neurons at baseline. (B) Mitochondrial membrane potential of primary cortical neurons from WT and BAC-HD mice, treated with vehicle or bexarotene (500 nM), was determined from the ratio of mitochondrial to cytosolic JC-1 fluorescence. *P < 0.05, Student’s t test. n = 3 biological replicates; n = 3 technical replicates. Results were normalized to WT mouse neurons at baseline. Similar results were obtained using tetramethylrhodamine methyl ester (TMRM) as the fluorescent probe (fig. S1B). (C) We quantified active caspase-3 immunostaining of primary cortical neurons from WT and BAC-HD mice, treated with vehicle or bexarotene (500 nM) for 24 hours and H2O2 (25 μM) for 4 hours. *P < 0.05, **P < 0.01, Student’s t test. n = 3 biological replicates; 30 to 50 cells were counted per experiment. (D) Mitochondrial membrane potential was measured in BAC-HD mouse primary cortical neurons, transfected with the indicated short hairpin RNA (shRNA) expression vector (control = scrambled shRNA), and treated with vehicle or bexarotene (500 nM). Mitochondrial membrane potential was determined from the ratio of mitochondrial to cytosolic JC-1 fluorescence. *P < 0.05, ANOVA with post-hoc Tukey test. n = 3 biological replicates; n = 3 technical replicates. Results were normalized to WT mouse neurons at baseline as in (B). (E) We quantified active caspase-3 immunostaining of BAC-HD mouse primary cortical neurons, transfected with the indicated shRNA expression vectors, and treated with vehicle or bexarotene (500 nM) for 24 hours and H2O2 (25 μM) for 4 hours. *P < 0.05, ANOVA with post-hoc Tukey test. n = 3 biological replicates; 30 to 50 cells were counted per experiment. (F) We performed reverse transcription polymerase chain reaction (RT-PCR) analysis of RNA expression of the PPARδ target genes pyruvate dehydrogenase kinase isoform 4 (PDK4), angiopoietin-like 4 (Angptl4), and uncoupling protein 2 (UCP2) in BAC-HD mouse primary cortical neurons, treated as indicated. **P < 0.01, ANOVA with post-hoc Tukey test. n = 6 independent experiments. Error bars represent SEM. Audrey S. Dickey et al., Sci Transl Med 2017;9:eaal2332 Published by AAAS